Kepos Capital’s Cano Health, Inc. CANO Stock Holding History

Kepos Capital’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-500	Closed	-$318K	–	604
2022 Q1	$318K	Hold	500	–	–	0.02%	263
2021 Q4	$446K	Hold	500	–	–	0.04%	281
2021 Q3	$634K	Buy	+500	New	+$606K	0.04%	334
2021 Q1	–	Sell	-750	Closed	-$1.01M	–	458
2020 Q4	$1.01M	Sell	750 -11,172	-94%	-$12.8M	0.09%	205
2020 Q3	$12.4M	Buy	+11,922	New	+$12.5M	1.32%	15

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kepos Capital's CANO Position: Q2 2022 in Review

Kepos Capital sold out of Cano Health, Inc. (CANO) in Q2 2022, closing a stake of 500 shares — an estimated $318K sold.

Kepos Capital first reported a position in CANO in Q3 2020 and held it in 5 quarters. The position peaked at $12.4M in Q3 2020. 144 funds tracked by Wall St. Rank hold CANO as of Q2 2022.

Kepos Capital reported no remaining Cano Health, Inc. position as of Q2 2022 after selling out during the quarter.
Kepos Capital sold 500 Cano Health, Inc. shares in Q2 2022, an estimated $318K.
Kepos Capital first reported a position in Cano Health, Inc. in Q3 2020 and held it in 5 quarters.
Kepos Capital's Cano Health, Inc. position peaked at $12.4M in Q3 2020.
144 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2022.

Based on Kepos Capital's 13F filing for Q2 2022, filed 12 Aug 2022.